iTunes

Iniciando iTunes Store.Si iTunes no se inicia, haz clic en el icono de la aplicación iTunes en el Dock de Mac o en el escritorio de Windows.Progress Indicator
Abriendo el iBooks Store.Si iBooks no se abre, haz clic en la app iBooks del Dock.Progress Indicator
iTunes

iTunes is the world's easiest way to organize and add to your digital media collection.

No encontramos iTunes en este ordenador. Para comprar y descargar ATP3 Lipids Cholesterol Management de Evan Schoenberg, obtén iTunes ya.

¿Ya tienes iTunes? Haz clic en Ya tengo iTunes, para que sea activado.

I Have iTunes Descarga gratis
iTunes para Mac y PC

ATP3 Lipids Cholesterol Management

Por Evan Schoenberg

Abre iTunes para comprar y descargar Apps.

Descripción

Cholesterol management is a complex, necessary task in a huge number of patient encounters. We know that getting it right is a vital part of promoting long-term health. Let ATP3 Lipids help!

The Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults - or the ATP III for short - describes the evidence-based cholesterol testing and management recommendations of the National Cholesterol Education Program. These guidelines categorize lipid levels by lipoprotein type, define cholesterol goals based on specific patient characteristics, and describe therapeutic recommendations for management of cholesterol and the metabolic syndrome.

ATP3 Lipids puts fast and thorough access to this cholesterol management algorithm on your iPhone or iPod Touch, from your patients' specific cholesterol goals to details of cholesterol management drugs (dosing, percentage change, side effects, and contraindications).

You input your patients' data - lipid panel by numbers and risk factors by simply tapping to select. Input is beautiful and easy, using the popular interface from MediMath.

ATP3 Lipids then shows you the lipid classifications and specific therapeutic recommendations of the ATP III based on the lipid panel and risk factors. You can tap a recommendation to view further information.

ATP3 Lipids includes a complete Framingham Cardiac Risk calculator which is automatically presented for use if the patient's risk factors indicate a need to evaluate the hard 10-year cardiac risk.

The info button at the top-right displays the ATP III algorithm and reference tables in textual form (the Quick Desk Reference on which the ATP3 Lipids therapeutic recommendations are based). Tapping the 'Show Full Report' button from the info screen switches to the complete 284 page ATP III final report.

ATP3 Lipids keeps track of the last information you entered and restores it when launched, with a Clear button easily accessible to begin working up the next patient.

FEATURES

• ATP III based, patient-specific cholesterol goals
• ATP III based, patient-specific therapeutic recommendations
• Lipid lowering drug reference, with dosing, expected lipid effects, side effects, and contraindications
• Metabolic syndrome reference, with criteria and recommendations
• Both executive summary and complete text of the ATP III report included
• Support for US and SI units

If you love the program, please leave a review. If you have comments, suggestions, or questions, please contact me directly at support@atp3lipids.com as it's not possible to respond to reviews.

Novedades de la versión 1.8

• Updates for iOS 8, iPhone 6, iPhone 6+
• General bug fixes

Captura de pantalla del iPhone

Captura de pantalla del iPhone 1
Captura de pantalla del iPhone 2
ATP3 Lipids Cholesterol Management
Ver en iTunes
  • USD 1.99
  • Categoría: Medicina
  • Actualizado :
  • Versión: 1.8
  • Tamaño: 2.0 MB
  • Idioma: Inglés
  • Vendedor:
Para descargar esta aplicación debes ser mayor de 17 años de edad
  • Información médica y de tratamiento frecuente/intensa

Compatibilidad: Requiere iOS 8.1 o posterior. Compatible con iPhone, iPad y iPod touch. Esta app está optimizada para iPhone 5, iPhone 6 y iPhone 6 Plus.

Valoraciones de clientes

No hemos recibido suficientes valoraciones para poder mostrar un promedio de la versión actual de este artículo.